<DOC>
	<DOCNO>NCT00665574</DOCNO>
	<brief_summary>To evaluate safety performance ActaViscâ„¢ intra-articular injection ( ActaVisc ) ActaVisc Mx , management pain associate osteoarthritis knee patient fail respond adequately conservative non-pharmacologic therapy simple analgesic</brief_summary>
	<brief_title>ActaVisc ActaVisc Mx Intra-articular Injection Pain Associated With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Osteoarthritis ( OA ) grade 2 3 . Symptoms treatment knee least 12 month . Fully ambulatory patient . Secondary OA result rheumatoid arthritis , chondrocalcinosis , osteonecrosis , chronic fibromyalgia autoimmune disease . Generalized symptomatic OA low extremity joint knee , inflammatory joint disease , bursitis , OA hips , condition may interfere study assessment .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>